Insight Molecular Diagnostics (IMDX) Gains from Sales and Divestitures (2024 - 2025)
Insight Molecular Diagnostics' (IMDX) quarterly Gains from Sales and Divestitures came in at $86000.0 in Q4 2025, up 405.88% year-on-year from $17000.0 in Q4 2024, and up 405.88% quarter-over-quarter from $17000.0 in Q4 2024.
Insight Molecular Diagnostics (IMDX) Gains from Sales and Divestitures (2024 - 2025) Analysis & Trends
Insight Molecular Diagnostics has disclosed Gains from Sales and Divestitures across 2 years of filings, most recently posting $86000.0 for Q4 2025.
- Gains from Sales and Divestitures for Q4 2025 came in at $86000.0, up 405.88% year-over-year; the trailing twelve-month figure through Dec 2025 was $86000.0 (up 405.88% YoY), and the FY2025 annual result was $86000.0, up 405.88% from the prior year.
- Gains from Sales and Divestitures came in at $86000.0 for Q4 2025 at Insight Molecular Diagnostics, up from $17000.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $86000.0 in Q4 2025 to a low of $4000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 4.44 Mn | -24.49 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 86,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |